LONA — LeonaBio
Median target
$16
calls from the last 12 months
Implied return
+235.4%
median target vs. price
Coverage
3 analysts · 3 calls
updated in the last 12 months
Consensus
3/0/0+3 net
Buy / Hold / Sell
Which analysts are behind LONA's consensus?
See every current rating, price target and the analysts' track records for LeonaBio — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 3 analysts with calls on LONA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
LONA elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-11-04 | Insiders | Great Point Partners, Llc | 13G stake | 5.0% of class · new position | 474.3K sh |
| 2026-11-04 | Insiders | Dr. Jeffrey R. Jay, M.D. | 13G stake | 5.0% of class · new position | 474.3K sh |
| 2026-11-04 | Insiders | Ms. Lillian Nordahl | 13G stake | 5.0% of class · new position | 474.3K sh |
| 2026-10-26 | Insiders | Portman David J.10% owner | Insider purchase | 3.1M sh @ $3149.47 | $9.9B |
More: insider activity · executive branch · trending